Regulatory information

This website is informational only. No products are sold directly through this site. Medical cannabis products require valid prescriptions and dispensing through licensed channels in each jurisdiction.

Access, prescribing rules, and product availability vary by country and region. Nothing on this site constitutes medical advice or a therapeutic claim for any Phant product.

United Kingdom: Products distributed in the United Kingdom are classified and supplied as Cannabis-Based Products for Medicinal Use (CBPMs) under Schedule 2 of the UK Misuse of Drugs Regulations 2001, released in line with MHRA guidance for unlicensed CBPMs.

Products in other markets are supplied in compliance with the applicable regulatory requirements of each jurisdiction. This site is intended for medical professionals, licensed distributors, and qualified procurement teams — not for patient self-referral or recreational use.

For regulatory enquiries: info@cnpg.ca

Version 1.0 · Review annually · Produced by CNPG / Phant.

Our Markets

Active supply across five international markets.

Each market served through locally licensed distribution channels. Contact us to discuss your jurisdiction.

United Kingdom

Active

Flower · Cannabis Flower Extracts · Live Resin · Distillate · Oral Oil

Germany

Active

Cannabis Extract · Licensed distribution established

Czech Republic

Active

Cannabis Extract · Licensed distribution established

South Africa

Active

Bulk Live Resin · For licensed processors

Australia

Active

THCa · Bulk formats · For licensed processors

Contact

Three points of contact, one organisation.

For prescriber documentation, supply enquiries, distribution partnerships, or new market discussions — get in touch with the CNPG team directly.

General Enquiries

All general inbound enquiries — directed here first.

Generalinfo@cnpg.ca

Product Enquiries

Product information, documentation, and clinical enquiries about specific Phant products.

Productsinfo@cnpg.ca

Sales & Distribution

Distribution partnerships, wholesale, new market discussions, and bulk supply enquiries.

Salessales@cnpg.ca
Send an Enquiry

Regulatory note — Products distributed in the United Kingdom are classified and supplied as Cannabis-Based Products for Medicinal Use (CBPMs) under Schedule 2 of the UK Misuse of Drugs Regulations 2001, released in line with MHRA guidance for unlicensed CBPMs. Products in other markets are supplied in compliance with the applicable regulatory requirements of each jurisdiction. This website is intended for medical professionals, licensed distributors, and qualified procurement teams. Not for patient self-referral or recreational use. Version 1.0 · April 2026 · Review annually. Produced by CNPG / Phant.

Canadian National Pharma Group
Health Canada licensed
Phant Medical

Markets

United Kingdom
Germany
Czech Republic
South Africa
Australia

Contact

info@cnpg.ca
sales@cnpg.ca

Compliance

Canadian GMP / GPP
GACP · Health Canada
MHRA compliant (UK)
Schedule 2 · UK

Privacy Cookies Terms of use Regulatory information

© Canadian National Pharma Group 2026 · Phant Medical · All rights reserved